Today's approach to personalized cancer therapy depends on fragmented processes that do not scale. Echo is building the infrastructure that connects tumor analysis, target selection, GMP manufacturing, regulatory workflows, and immune monitoring into a single operating system.

By working with clinical, academic, and industry partners, we can help accelerate development, expand access, and move individualized cancer vaccines closer to routine care.